Mitoxantrone hydrochloride

CAS No. 70476-82-3

Mitoxantrone hydrochloride ( NCI 301739; Novantrone; NSC 301739 )

Catalog No. M15709 CAS No. 70476-82-3

Mitoxantrone Dihydrochloride, a type II topoisomerase inhibitor, is an anthracenedione-derived antineoplastic agent.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 45 In Stock
100MG 65 In Stock
500MG 165 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Mitoxantrone hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Mitoxantrone Dihydrochloride, a type II topoisomerase inhibitor, is an anthracenedione-derived antineoplastic agent.
  • Description
    Mitoxantrone Dihydrochloride, a type II topoisomerase inhibitor, is an anthracenedione-derived antineoplastic agent.
  • Synonyms
    NCI 301739; Novantrone; NSC 301739
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Topoisomerase
  • Recptor
    Topo II
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    70476-82-3
  • Formula Weight
    517.40
  • Molecular Formula
    C22H30Cl2N4O6
  • Purity
    >98%(HPLC)
  • Solubility
    Water: 89 mg/mL (172.01 mM); DMSO: 89 mg/mL (172.01 mM)
  • SMILES
    Cl.Cl.OCCNCCNC1=C2C(=O)C3=C(O)C=CC(O)=C3C(=O)C2=C(NCCNCCO)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Seitz M. Curr Opin Rheumatol, 1999, 11(3), 226-232.
molnova catalog
related products
  • UAMC 00039 dihydroch...

    UAMC00039 dihydrochloride is a potent, reversible and competitive dipeptidyl peptidase II inhibitor with an IC50 of 0.48 nM.

  • Topotecan hydrochlor...

    Topotecan HCl (SKF 104864A; NSC 609669) is the first topoisomerase I-directed cytotoxic agent to enter clinical trials in the United States.

  • Amonafide

    A novel topoisomerase II (Topo II) inhibitor and DNA intercalator that induces apoptotic signaling by blocking the binding of Topo II to DNA.